Tangerine peel contains a compound that can kill certain human cancer cells, new research from the Leicester School of Pharmacy has revealed.
The research, which was presented at the British Pharmaceutical Conference in Manchester last week, revealed that human cancer cells, which contain an enzyme called P450 CYP1B1, were destroyed by a compound called Salvestrol Q40 contained in tangerine peel.
The researchers have formed a private company, called Nature’s Defence Investments, to protect and promote their research, with the potential of designing a natural anti-cancer alternative based on this technology.
